Deciphera Pharmaceuticals, Inc. (DCPH) Financials
DCPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 473.6 million | 122.7 million |
| 2023-09-30 | 497.8 million | 116.2 million |
| 2023-06-30 | 509.6 million | 105.2 million |
| 2023-03-31 | 549.0 million | 108.9 million |
DCPH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -28.9 million | 14.1 million |
| 2023-09-30 | -29.9 million | 11.2 million |
| 2023-06-30 | -38.9 million | 12.9 million |
| 2023-03-31 | -49.8 million | 12.5 million |
DCPH Net Income
No data available :(
DCPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 306.2 million | - | 25.9 million |
| 2023-09-30 | 339.1 million | - | 26.7 million |
| 2023-06-30 | 328.7 million | - | 27.5 million |
| 2023-03-31 | 398.6 million | - | 28.3 million |
DCPH Shares Outstanding
DCPH Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 63000 | 58.6 million | 39.1 million | - |
| 2023-09-30 | 62000 | 62.5 million | 33.3 million | - |
| 2023-06-30 | 293000 | 58.3 million | 32.6 million | - |
| 2023-03-31 | 360000 | 54.8 million | 31.4 million | - |
DCPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 48.3 million | 1.8 million |
| 2023-09-30 | 43.3 million | 1.3 million |
| 2023-06-30 | 38.3 million | 173000 |
| 2023-03-31 | 33.4 million | 488000 |
DCPH
Price: $25.38
52 week price:
Earnings Per Share: -2.29 USD
P/E Ratio: -6.67
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 800800
Ebitda: -12.0 millionMarket Capitalization: 2.1 billion